Low Levels of Metrnl are Linked to the Deterioration of Diabetic Kidney Disease
Jin Chen,Zhi-Yong Li,Fei Xu,Chao-Qun Wang,Wen-Wen Li,Jin Lu,Chao-Yu Miao
DOI: https://doi.org/10.2147/dmso.s452055
2024-02-26
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Jin Chen, 1, 2, &ast Zhi-Yong Li, 2, &ast Fei Xu, 2, &ast Chao-Qun Wang, 1 Wen-Wen Li, 1 Jin Lu, 1 Chao-Yu Miao 2 1 Department of Endocrinology and Metabolism, Changhai Hospital, Second Military Medical University/Naval Medical University, Shanghai, People's Republic of China; 2 Department of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chao-Yu Miao, Department of Pharmacology, Second Military Medical University/Naval Medical University, 325 Guo He Road, Shanghai, 200433, People's Republic of China, Email Jin Lu, Department of Endocrinology and Metabolism, Changhai Hospital, Second Military Medical University/Naval Medical University, 168 Chang Hai Road, Shanghai, 200433, People's Republic of China, Email Objective: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease. Metrnl is a secreted protein that plays an important role in kidney disease. The aim of this study was to investigate DKD-related factors and the correlation between serum Metrnl levels and the severity of DKD. Methods: Ninety-six type 2 diabetes mellitus (T2DM) patients and 45 DKD patients were included in the study. A range of parameters were measured simultaneously, including waist-to-hip ratio (WHR), body mass index (BMI), urinary albumin/creatinine ratio (UACR), monocyte–lymphocyte ratio (MLR), albumin/globulin (A/G), liver and kidney function, blood lipid profile, islet function, and others. Subsequently, the related factors and predictive significance of DKD were identified. The correlation between the relevant factors of DKD and serum Metrnl levels with DKD was evaluated. Results: The duration of the disease (OR: 1.12, 95% CI: 1.01– 1.24, P =0.031), hypertension (OR: 4.86, 95% CI: 1.16– 20.49, P =0.031), fasting blood glucose (OR: 1.23, 95% CI: 1.03– 1.48, P =0.025), WHR (OR: 2.53, 95% CI: 1.03– 6.22, P =0.044), and MLR (OR: 1.91, 95% CI: 1.18– 3.08, P =0.008) are independent risk factors for DKD (P < 0.05). Conversely, A/G (OR: 0.13, 95% CI: 0.02– 0.76, P =0.024) and Metrnl (OR: 0.99, 95% CI: 0.98– 1.00, P =0.001) have been identified as protective factors against DKD. Furthermore, the level of Metrnl was negatively correlated with the severity of DKD (r s =− 0.447, P < 0.001). The area under receiver operating characteristic (ROC) curves for the diagnostic accuracy of Metrnl for DKD is 0.765 (95% CI: 0.686– 0.844). Conclusion: The duration of the disease, hypertension, fasting blood glucose, WHR, and MLR are major risk factors for DKD. Metrnl and A/G are protective factors for DKD. Serum Metrnl concentrations are inversely correlated with DKD severity. Keywords: diabetic kidney disease, urinary albumin/creatinine ratio, Metrnl, albumin/globulin Urinary albumin/creatinine ratio (UACR) is a recognized risk factor and a surrogate marker for microvascular disease, such as diabetic kidney disease (DKD). 1 Clinically, DKD can be divided into micro- or macro-albumin according to UACR (30–300 mg/g or >300 mg/g). 2 With the worldwide increase in diabetes prevalence, the number of DKD patients is expected to increase, 3 and it will increase by about 50% in the next 24 years, from 537 million to 783 million. 4 DKD is a severe complication of diabetes mellitus, and it is the main cause of end-stage renal disease (ESRD) worldwide. 5,6 DKD severely reduces the quality of life of patients with long diabetic duration. Patients with DKD have higher risks of ESRD, cardiovascular disease (CVD), and even death compared to diabetic patients without kidney disease. 7 Therefore, identifying the risk and protective factors for DKD is of great importance. The pathogenesis of DKD is extremely complicated, and its underlying molecular mechanism has not yet been thoroughly elucidated. During the occurrence and development of DKD, kidney cells, including glomerular membrane cells, podocyte, endothelial cells, smooth muscle cells, and inflammatory cells are affected by hyperglycemia. 8 Many clinical biomarkers can reflect microvascular damage and are associated with the risk of microvascular disease development in T2DM patients. Inflammation has always been paid attention to the progress of DKD. Monocyte–lymphocyte ratio (MLR) is a novel inflammatory marker. 9 There are studies reporting a significant correlation between monocytes and serum albumin in the circulation with proteinuria. 10 Metrnl is -Abstract Truncated-
endocrinology & metabolism